trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Goldenhar Syndrome D006053 1 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Myopathy, Central Core D020512 1 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Adenomyosis D062788 1 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Visceral Pain D059265 1 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Capsule Opacification D058442 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Hypesthesia D006987 1 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sasaki Y et al. p53 negatively regulates the hepatoma growth factor HDGF. 2011 Cancer Res. pmid:22006999
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Li S et al. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. 2011 Mol. Cancer pmid:21314984
Kumar A et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. 2011 Int. J. Radiat. Biol. pmid:21815748
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Salvi V et al. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 2010 Sep-Oct Immunobiology pmid:20573419
Luo W et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. 2010 Cancer Res. pmid:20587525
Zaman MS et al. The functional significance of microRNA-145 in prostate cancer. 2010 Br. J. Cancer pmid:20588276
Shu ST et al. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. 2010 Anticancer Res. pmid:20651337
Paddock MN et al. The BRCT domain of PARP-1 is required for immunoglobulin gene conversion. 2010 PLoS Biol. pmid:20652015
Mossman D et al. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. 2010 BMC Cancer pmid:20618997
Ma J et al. Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. 2010 Carcinogenesis pmid:20622005
Chen J et al. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. 2010 Epigenetics pmid:20505343
Liu YW et al. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells. 2010 J. Cell. Biochem. pmid:20506344
Kitamoto S et al. Promoter hypomethylation contributes to the expression of MUC3A in cancer cells. 2010 Biochem. Biophys. Res. Commun. pmid:20510874
Liang Q et al. The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers. 2010 Int. J. Cancer pmid:20112338
Beedanagari SR et al. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. 2010 Toxicol. Lett. pmid:20116417
Lu Y et al. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. 2010 Hum. Reprod. pmid:20118114
Davies GF et al. Troglitazone inhibits histone deacetylase activity in breast cancer cells. 2010 Cancer Lett. pmid:19699029
Wu Y et al. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. 2010 BMC Cancer pmid:20132554
Kim TH et al. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. 2010 Int. Immunopharmacol. pmid:20728595
Aoyama M et al. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. 2010 Nutrition pmid:20004081
Ji P et al. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. 2010 Haematologica pmid:20823130
Nunes MJ et al. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. 2010 J. Neurochem. pmid:20096088
Weng YI et al. Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. 2010 Toxicol. Appl. Pharmacol. pmid:20678512
Aizawa S and Yamamuro Y Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. 2010 Neurochem. Int. pmid:20100532
Tamannai M et al. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. 2010 Oncol. Res. pmid:20681406
Wu J et al. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. 2010 Acta Pharmacol. Sin. pmid:20048748
Sonnemann J et al. Serine proteases in histone deacetylase inhibitor-induced apoptosis. 2010 Mol. Cancer Ther. pmid:20682651
Hebbel RP et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. 2010 Blood pmid:20053759
Fu J et al. Discovery of 1H-benzo[d][1,2,3]triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. 2010 Bioorg. Med. Chem. pmid:21067930
He R et al. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. 2010 J. Med. Chem. pmid:20055418
Nicodeme E et al. Suppression of inflammation by a synthetic histone mimic. 2010 Nature pmid:21068722
Xu J et al. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. 2010 Breast Cancer Res. Treat. pmid:19466541
Watson JA et al. Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles. 2010 J. Cell. Mol. Med. pmid:19583812
Song S et al. Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1. 2010 Cardiovasc. Res. pmid:19633316
Eskeland R et al. Histone acetylation and the maintenance of chromatin compaction by Polycomb repressive complexes. 2010 Cold Spring Harb. Symp. Quant. Biol. pmid:21502416
Zein S et al. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. 2010 Exp. Biol. Med. (Maywood) pmid:20975082
Chao KC et al. Anti-tumor activity of histone deacetylase inhibitors and the effect on ATP-binding cassette in ovarian carcinoma cells. 2010 Eur. J. Gynaecol. Oncol. pmid:20882882
Lee CS et al. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines. 2010 Eur. J. Pharmacol. pmid:20868669
Yuan GB et al. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells. 2010 Chin J Cancer pmid:20346212
Wang QH et al. Opposite effects of Trichostatin A on activation of mast cells by different stimulants. 2010 FEBS Lett. pmid:20371366
Simboeck E et al. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. 2010 J. Biol. Chem. pmid:20952396
Marumo T et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. 2010 Am. J. Physiol. Renal Physiol. pmid:19906951
Yakovlev A et al. Epigenetic regulation of caspase-3 gene expression in rat brain development. 2010 Gene pmid:19909801
Freidkin I et al. Effects of histone deacetylase inhibitors on rat mesangial cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19923417
Perisic T et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. 2010 Neuropsychopharmacology pmid:19924110
Li X et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. 2010 Br. J. Haematol. pmid:19807731
Ninios YP et al. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A. 2010 Leuk. Res. pmid:19782399
Higashiyama R et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. 2010 Mod Rheumatol pmid:19784544